RANCHO CUCAMONGA, CA — May 6, 2026 — Leads & Copy — Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that CFO Bill Peters and EVP of Regulatory Affairs and Clinical Operations Tony Marrs will present at the 2026 Bank of America Health Care Conference on Wednesday, May 13, 2026, at 3:00 pm PT.
The presentation will be webcast, and access will be available on Amphastar Pharmaceuticals’ website.
The webcast will be available for 30 days following the presentation.
Amphastar Pharmaceuticals focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. The company also sells active pharmaceutical ingredients, or API products.
Most of Amphastar’s finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers.
Amphastar’s logo and other trademarks or service marks of Amphastar, including Amphastar®, BAQSIMI®, Primatene MIST®, REXTOVY®, Amphadase®, and Cortrosyn®, are the property of Amphastar.
Source: Amphastar Pharmaceuticals, Inc.
